What changed in SANGAMO THERAPEUTICS, INC's 2025 10-K compared to 2024?

Across the narrative sections we track, SANGAMO THERAPEUTICS, INC (SGMO) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this SGMO 10-K diff come from?

The source filings are SANGAMO THERAPEUTICS, INC's official 2024 and 2025 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

SANGAMO THERAPEUTICS, INCSGMO決算レポート

Nasdaq · ヘルスケア · 生物製品（診断物質を含まない）

詳細分析

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.

What changed in SANGAMO THERAPEUTICS, INC's 10-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other SGMO 10-K year-over-year comparisons

SGMO 10-K 2023 vs 2024
SGMO 10-K 2022 vs 2023